These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7985934)

  • 1. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP; van der Meché FG; Schmitz PI
    Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508
    [No Abstract]   [Full Text] [Related]  

  • 3. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.
    Hughes RA; Hadden RD; Rees JH; Swan AV
    Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM; Pizza V; Stella L
    Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational therapy of Guillain-Barré syndrome.
    Raphael JC; Chevret S
    Lancet; 1998 Mar; 351(9104):753. PubMed ID: 9504542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
    van der Meché FG
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Guillain-Barré syndrome: diagnosis, treatment and prognosis.
    van der Meché FG
    Acta Neurol Belg; 1994; 94(2):124-7. PubMed ID: 8036879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP; van der Meché FG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing views of Guillain-Barré syndrome.
    Asbury AK; McKhann GM
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guillain-Barré syndrome and plasma exchange].
    Raphael JC; Elkharrat D; Chevret S; Vercken JB; Chastang C; Gajdos P
    Ann Med Interne (Paris); 1990; 141(7):593-6. PubMed ID: 2085236
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillian-Barre syndrome: issues in etiology and management.
    Garg RK
    Indian Pediatr; 1997 Jan; 34(1):74-7. PubMed ID: 9251289
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B; Jarjour IT
    Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.